TA-A002

N/A

Report date: 2023/05/22 10:15:54
NME

Base Information

Drug NameTA-A002
Drug Alias NameTA-A002
ClassificationSmall molecules
Mechanisms of ActionCannabinoid CB2 receptor agonistsCannabinoid CB1 receptor agonists
TargetsCannabinoid CB1 receptorCannabinoid CB2 receptor
Therapy Area/IndicationsChemotherapy-induced nausea and vomiting
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTALLC Corporation Inc
China Registration ClassN/A

Develop Information

Active CompaniesTALLC Corporation Inc
Inactive CompaniesN/A
Active IndicationsChemotherapy-induced nausea and vomiting
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A